221 related articles for article (PubMed ID: 8727138)
21. Evaluation of polyinosinic-polycytidylic and poly-L-lysine in metastatic breast cancer.
Theriault RL; Hortobagyi GN; Buzdar AU; Levy HB; Hersh EM
Cancer Treat Rep; 1986 Nov; 70(11):1341-2. PubMed ID: 3768878
[No Abstract] [Full Text] [Related]
22. Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent manners.
Zhu X; Fallert-Junecko BA; Fujita M; Ueda R; Kohanbash G; Kastenhuber ER; McDonald HA; Liu Y; Kalinski P; Reinhart TA; Salazar AM; Okada H
Cancer Immunol Immunother; 2010 Sep; 59(9):1401-9. PubMed ID: 20549206
[TBL] [Abstract][Full Text] [Related]
23. Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice.
Kende M; Lupton HW; Rill WL; Levy HB; Canonico PG
Antimicrob Agents Chemother; 1987 Jul; 31(7):986-90. PubMed ID: 3662477
[TBL] [Abstract][Full Text] [Related]
24. Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas.
Pollack IF; Jakacki RI; Butterfield LH; Hamilton RL; Panigrahy A; Potter DM; Connelly AK; Dibridge SA; Whiteside TL; Okada H
J Clin Oncol; 2014 Jul; 32(19):2050-8. PubMed ID: 24888813
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors for deep situated malignant gliomas treated with linac radiosurgery.
Wang YY; Yang GK; Li SY; Baol XF; Wu CY
Chin Med Sci J; 2004 Jun; 19(2):105-10. PubMed ID: 15250245
[TBL] [Abstract][Full Text] [Related]
26. A phase I study of multi-HLA-binding peptides derived from heat shock protein 70/glypican-3 and a novel combination adjuvant of hLAG-3Ig and Poly-ICLC for patients with metastatic gastrointestinal cancers: YNP01 trial.
Nakajima M; Hazama S; Tamada K; Udaka K; Kouki Y; Uematsu T; Arima H; Saito A; Doi S; Matsui H; Shindo Y; Matsukuma S; Kanekiyo S; Tokumitsu Y; Tomochika S; Iida M; Yoshida S; Nakagami Y; Suzuki N; Takeda S; Yamamoto S; Yoshino S; Ueno T; Nagano H
Cancer Immunol Immunother; 2020 Aug; 69(8):1651-1662. PubMed ID: 32219501
[TBL] [Abstract][Full Text] [Related]
27. Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer.
Levine AS; Sivulich M; Wiernik PH; Levy HB
Cancer Res; 1979 May; 39(5):1645-50. PubMed ID: 371793
[No Abstract] [Full Text] [Related]
28. Interferon induction in piglets with polyinosinic:polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
Loewen KG; Derbyshire JB
Res Vet Sci; 1988 Jan; 44(1):132-3. PubMed ID: 2453906
[TBL] [Abstract][Full Text] [Related]
29. Immune response modifying activity in mice of polyinosinic: polycytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly-ICLC].
Chirigos MA; Papademetriou V; Bartocci A; Read E; Levy HB
Int J Immunopharmacol; 1981; 3(4):329-37. PubMed ID: 7333719
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose.
Talmadge JE; Adams J; Phillips H; Collins M; Lenz B; Schneider M; Chirigos M
Cancer Res; 1985 Mar; 45(3):1066-72. PubMed ID: 3971361
[TBL] [Abstract][Full Text] [Related]
31. Poly ICLC inhibits Plasmodium cynomolgi B malaria infection in rhesus monkeys.
Puri SK; Dutta GP; Levy HB; Maheshwari RK
J Interferon Cytokine Res; 1996 Jan; 16(1):49-52. PubMed ID: 8640451
[TBL] [Abstract][Full Text] [Related]
32. Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models.
Zhu X; Nishimura F; Sasaki K; Fujita M; Dusak JE; Eguchi J; Fellows-Mayle W; Storkus WJ; Walker PR; Salazar AM; Okada H
J Transl Med; 2007 Feb; 5():10. PubMed ID: 17295916
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Effect of Irreversible Electroporation in Combination with Poly-ICLC Adjuvant in Preclinical Models of Hepatocellular Carcinoma.
Vivas I; Iribarren K; Lozano T; Cano D; Lasarte-Cia A; Chocarro S; Gorraiz M; Sarobe P; Hervás-Stubbs S; Bilbao JI; Casares N; Lasarte JJ
J Vasc Interv Radiol; 2019 Jul; 30(7):1098-1105. PubMed ID: 31101416
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial.
Salazar AM; Erlich RB; Mark A; Bhardwaj N; Herberman RB
Cancer Immunol Res; 2014 Aug; 2(8):720-4. PubMed ID: 24801836
[TBL] [Abstract][Full Text] [Related]
35. Activation of natural killer cells in newborn piglets by interferon induction.
Lesnick CE; Derbyshire JB
Vet Immunol Immunopathol; 1988 Mar; 18(2):109-17. PubMed ID: 2838948
[TBL] [Abstract][Full Text] [Related]
36. Poly-ICLC preconditioning protects the blood-brain barrier against ischemic injury in vitro through type I interferon signaling.
Gesuete R; Packard AE; Vartanian KB; Conrad VK; Stevens SL; Bahjat FR; Yang T; Stenzel-Poore MP
J Neurochem; 2012 Nov; 123 Suppl 2(Suppl 2):75-85. PubMed ID: 23050645
[TBL] [Abstract][Full Text] [Related]
37. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
Vymazal J; Wong ET
Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
[TBL] [Abstract][Full Text] [Related]
38. Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.
Okada H; Butterfield LH; Hamilton RL; Hoji A; Sakaki M; Ahn BJ; Kohanbash G; Drappatz J; Engh J; Amankulor N; Lively MO; Chan MD; Salazar AM; Shaw EG; Potter DM; Lieberman FS
Clin Cancer Res; 2015 Jan; 21(2):286-94. PubMed ID: 25424847
[TBL] [Abstract][Full Text] [Related]
39. Tumor response to interferon inducer and radiation effect of serum interferon levels.
Lvovsky EA; D'Souza J; Eng D; D'Souza D; Lvovsky B; Hetland R; Craver WL; Sobel SH
J Biol Regul Homeost Agents; 1988; 2(1):1-6. PubMed ID: 2459908
[TBL] [Abstract][Full Text] [Related]
40. Dissociation of therapeutic and toxic effects of polyinosinic-polycytidylic acid admixed with poly-L-lysine and solubilized with carboxymethyl cellulose in tumor-bearing mice.
Hartmann D; Adams JS; Meeker AK; Schneider MA; Lenz BF; Talmadge JE
Cancer Res; 1986 Mar; 46(3):1331-8. PubMed ID: 3484679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
